Endoscopic Sleeve Gastroplasty vs Root-Cause Reset: Who Benefits and Who Should Proceed with Caution

Endoscopic Sleeve Gastroplasty vs Root-Cause Reset: Who Benefits and Who Should Proceed with Caution Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Endoscopic Sleeve Gastroplasty vs Root-Cause Reset: Who Benefits and Who Should Proceed with Caution. ... Think of this as a calm clinic conversation — structured, evidence-led, and aimed at real people over forty. ... We'll touch on Endoscopic Sleeve Gastroplasty, Tirzepatide Cycling, Root Cause Metabolic Reset — especially as they apply to real people over forty. ... Let's start with introduction. ... Endoscopic sleeve gastroplasty (ESG) has emerged as a minimally invasive endoscopic procedure that reduces stomach volume by 70-80% using sutures, delivering 15-20% total body weight loss without the incisions of traditional bariatric surgery. Yet in the landscape of metabolic health, ESG represents only one tool. The deeper question is whether patients truly need mechanical restriction or if a structured root-cause approach—addressing insulin resistance, visceral adiposity, gut microbiome disruption, and inflammatory cytokines—can achieve comparable or superior long-term outcomes with less risk. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/endoscopic-sleeve-gastroplasty-root-cause-vs-medication-only-who-it-helps-and-wh-4brmxx